5/2/25 20:41 | 4/30/25 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Forbes William P | NC | O | EVP,Chie | 2 | M.d | 0 | 0.00 | 0 | 16 | 15 | 123 | D | | | | | | | | | | | | | | |
5/2/25 20:32 | 4/30/25 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Duarte IRA | NC | O | EVP,CFO | 2 | M.d | 0 | 0.00 | 0 | 16 | 13 | 136 | D | | | | | | | | | | | | | | |
5/2/25 20:27 | 5/1/25 | AMPH | Amphastar Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Petersen Floyd F. | CA | D | | 3 | S | -54 | 27.11 | 0 | -2 | | 74 | D | | | | | | | | | | | | | | |
5/2/25 20:23 | 4/30/25 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | NC | DO | CEO | 3 | M.d | 0 | 0.00 | 0 | 111 | 35 | 426 | D | | | | | | | | | | | | | | |
5/2/25 20:00 | 5/1/25 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kihara James | CA | O | PRINCIPA | 8 | M.d | 63 | 5.45 | 0 | 12 | 96 | 24 | D | | | | | | | | | | | | | | |
5/2/25 20:00 | 5/2/25 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kihara James | CA | O | PRINCIPA | 8 | S.d | -63 | 5.45 | 0 | -12 | | 24 | D | | | | | | | | | | | | | | |
5/2/25 20:00 | 5/1/25 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 8 | M.d | 511 | 19.16 | 0 | 27 | 48 | 82 | D | | | | | | | | | | | | | | |
5/2/25 20:00 | 5/1/25 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 8 | S.d | -511 | 19.16 | 0 | -27 | | 82 | D | | | | | | | | | | | | | | |
5/2/25 19:59 | 5/1/25 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Schneyer Mark C. | CA | O | EVP,CFO | 8 | M.d | 161 | 5.40 | 0 | 30 | 90 | 63 | D | | | | | | | | | | | | | | |
5/2/25 19:59 | 5/2/25 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Schneyer Mark C. | CA | O | EVP,CFO | 8 | S.d | -161 | 5.40 | 0 | -30 | | 63 | D | | | | | | | | | | | | | | |
5/2/25 19:55 | 5/1/25 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gallagher Kathleen P. | CA | O | Chief Pr | 8 | M.d | 1,085 | 23.08 | 0 | 47 | 999% | 51 | D | | | | | | | | | | | | | | |
5/2/25 19:55 | 5/1/25 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gallagher Kathleen P. | CA | O | Chief Pr | 8 | S.d | -1,085 | 23.08 | 0 | -47 | | 51 | D | | | | | | | | | | | | | | |
5/2/25 18:18 | 5/2/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | 4 | S.d | -183 | 7.91 | 0 | -23 | | 40 | D | | | | | | | | | | | | | | |
5/2/25 17:04 | 4/30/25 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Blount Sally E. | IL | D | | 1 | S | -337 | 129.66 | 0 | -3 | | 34 | D | | | | | | | | | | | | | | |
5/2/25 16:55 | 5/1/25 | NAMS | Newamsterdam Pharma Co N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Lange Louis G | P7 | D | | 3 | M.d | 0 | 0.00 | 0 | 3 | 13 | 28 | I | | | | | | | | | | | | | | |
5/2/25 16:43 | 5/1/25 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 15 | M.d | 18,149 | 55.85 | 0 | 325 | 79 | 738 | I | | | | | | | | | | | | | | |
5/2/25 16:43 | 5/1/25 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 15 | S.d | -18,149 | 55.85 | 0 | -325 | | 738 | I | | | | | | | | | | | | | | |
5/2/25 16:38 | 5/1/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | CA | D | | 1 | P | 478 | 31.86 | 0 | 15 | 40 | 52 | D | | | | | | | | | | | | | | |
5/2/25 16:31 | 5/1/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 9 | M.d | 17,270 | 196.36 | 0 | 88 | | 37 | D | | | | | | | | | | | | | | |
5/2/25 16:31 | 5/1/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 9 | S.d | -17,270 | 196.36 | 0 | -88 | | 37 | D | | | | | | | | | | | | | | |
5/2/25 16:18 | 4/30/25 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Smart Dalton E. III | NJ | O | SVP Fin. | 3 | M.dm | 714 | 70.66 | 0 | 10 | | 8 | D | | | | | | | | | | | | | | |
5/2/25 16:17 | 5/1/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 8 | M.dm | 385 | 10.69 | 0 | 36 | 48 | 111 | D | | | | | | | | | | | | | | |
5/2/25 16:17 | 5/1/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 8 | S.dm | -385 | 10.69 | 0 | -36 | | 111 | D | | | | | | | | | | | | | | |
5/2/25 16:14 | 4/30/25 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Romanelli Joseph | NJ | O | P,Human | 1 | M.dm | 363 | 83.95 | 0 | 4 | 23 | 23 | D | | | | | | | | | | | | | | |
5/2/25 16:12 | 4/30/25 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Larson Betty D | NJ | O | EVP,CHRO | 1 | M.d | 961 | 84.71 | 0 | 11 | | 6 | D | | | | | | | | | | | | | | |
5/2/25 10:29 | 12/18/24 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Scully William P | FL | T | | 1 | P.m | 2,750 | 13.26 | 0 | 207 | 29 | 927 | M | | | | | | | | | | | | | | |
5/1/25 20:59 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Fisher Andrew | X0 | O | GC | 2 | M.d | 234 | 2.09 | 0 | 112 | 45 | 360 | D | | | | | | | | | | | | | | |
5/1/25 20:59 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Fisher Andrew | X0 | O | GC | 2 | S.d | -234 | 2.09 | 0 | -112 | | 360 | D | | | | | | | | | | | | | | |
5/1/25 20:58 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Zaccardelli David | X0 | DO | P,CEO | 2 | M.d | 811 | 2.54 | 0 | 320 | 2 | 14,377 | D | | | | | | | | | | | | | | |
5/1/25 20:58 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Zaccardelli David | X0 | DO | P,CEO | 2 | S.d | -811 | 2.54 | 0 | -320 | | 14,377 | D | | | | | | | | | | | | | | |
5/1/25 20:56 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Rickard Kathleen A. | X0 | O | Chief Me | 3 | M.d | 971 | 4.86 | 0 | 200 | 8 | 2,661 | D | | | | | | | | | | | | | | |
5/1/25 20:56 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Rickard Kathleen A. | X0 | O | Chief Me | 3 | S.d | -971 | 4.86 | 0 | -200 | | 2,661 | D | | | | | | | | | | | | | | |
5/1/25 20:55 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hahn Mark W | X0 | O | CFO | 2 | M.d | 811 | 2.54 | 0 | 320 | 2 | 13,466 | D | | | | | | | | | | | | | | |
5/1/25 20:55 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hahn Mark W | X0 | O | CFO | 2 | S.d | -811 | 2.54 | 0 | -320 | | 13,466 | D | | | | | | | | | | | | | | |
5/1/25 20:53 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Sinha Vikas | X0 | D | | 2 | M.d | 206 | 5.16 | 0 | 40 | 116 | 74 | D | | | | | | | | | | | | | | |
5/1/25 20:53 | 4/29/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Sinha Vikas | X0 | D | | 2 | S.d | -206 | 5.16 | 0 | -40 | | 74 | D | | | | | | | | | | | | | | |
5/1/25 19:23 | 4/30/25 | BTAI | Bioxcel Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mack David J. | CT | D | | 4 | M.d | 0 | 0.00 | 0 | 32 | 66 | 81 | D | | | | | | | | | | | | | | |
5/1/25 19:07 | 4/30/25 | ACRV | Acrivon Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Perceptive Advisors LLC | NY | T | | 3 | S.m | -8,591 | 1.52 | 0 | -5,657 | | 9,717 | I | | | | | | | | | | | | | | |
5/1/25 18:26 | 4/29/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Moat Ross | X0 | O | CHIEF CO | 6 | M.dm | 3,810 | 19.08 | 0 | 200 | | 28 | D | | | | | | | | | | | | | | |
5/1/25 18:26 | 4/29/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Moat Ross | X0 | O | CHIEF CO | 6 | S.dm | -3,810 | 19.08 | 0 | -200 | | 28 | D | | | | | | | | | | | | | | |
5/1/25 18:24 | 4/29/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 11 | M.dm | 6,360 | 19.27 | 0 | 330 | | 27 | D | | | | | | | | | | | | | | |
5/1/25 18:24 | 4/29/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 11 | S.dm | -6,360 | 19.27 | 0 | -330 | | 27 | D | | | | | | | | | | | | | | |
5/1/25 16:53 | 4/29/25 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 10 | M.d | 2,183 | 32.85 | 0 | 66 | | 19 | D | | | | | | | | | | | | | | |
5/1/25 16:53 | 4/29/25 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 10 | S.d | -2,183 | 32.85 | 0 | -66 | | 19 | D | | | | | | | | | | | | | | |
5/1/25 16:52 | 4/29/25 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazabraud Yann | MA | O | EVP,Head | 6 | S.dm | -7,054 | 34.96 | 0 | -202 | | 44 | D | | | | | | | | | | | | | | |
5/1/25 16:45 | 4/29/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 6 | M.dm | 3,243 | 38.61 | 0 | 84 | | 48 | D | | | | | | | | | | | | | | |
5/1/25 16:45 | 4/29/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 6 | S.dm | -3,243 | 38.61 | 0 | -84 | | 48 | D | | | | | | | | | | | | | | |
4/30/25 19:35 | 4/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | 2 | M.d | 39 | 3.15 | 0 | 12 | 25 | 62 | D | | | | | | | | | | | | | | |
4/30/25 19:35 | 4/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | 2 | S.d | -39 | 3.15 | 0 | -12 | | 62 | D | | | | | | | | | | | | | | |
4/30/25 19:35 | 4/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 4 | M.d | 159 | 7.20 | 0 | 22 | 145 | 37 | D | | | | | | | | | | | | | | |
4/30/25 19:35 | 4/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 4 | S.d | -159 | 7.20 | 0 | -22 | | 37 | D | | | | | | | | | | | | | | |
4/30/25 18:59 | 4/28/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 11 | M.d | 295 | 8.82 | 0 | 34 | | 23 | D | | | | | | | | | | | | | | |
4/30/25 18:59 | 4/28/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 11 | S.d | -295 | 8.82 | 0 | -34 | | 23 | D | | | | | | | | | | | | | | |
4/30/25 17:07 | 4/30/25 | ZNTL | Zentalis Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Myers Scott Dunseth | CA | D | | 1 | P | 29 | 1.40 | 0 | 21 | 8 | 281 | D | | | | | | | | | | | | | | |
4/30/25 16:45 | 4/28/25 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Selick Harold E | CA | D | | 1 | M.d | 12 | 1.16 | 0 | 11 | 32 | 44 | D | | | | | | | | | | | | | | |
4/30/25 16:17 | 3/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures 2014, L.P. | MA | T | | 1 | S.d | -2 | 1.05 | 0 | -2 | 0 | 3,209 | I | | | | | | | | | | | | | | |
4/30/25 16:15 | 4/28/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Adair Jason | NC | O | Chief Bu | 5 | S.d | -39 | 4.69 | 0 | -8 | | 184 | D | | | | | | | | | | | | | | |
4/30/25 16:09 | 3/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Evnin Luke | MA | DT | | 1 | S.d | -3 | 1.05 | 0 | -2 | 0 | 4,310 | I | | | | | | | | | | | | | | |
4/30/25 16:08 | 3/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gadicke Ansbert | MA | T | | 1 | S.d | -5 | 1.05 | 0 | -4 | 0 | 6,719 | I | | | | | | | | | | | | | | |
4/29/25 18:14 | 4/25/25 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Hirawat Samit | NJ | O | EVP,Chie | 3 | P.d | 302 | 6.02 | 0 | 50 | 150 | 84 | D | | | | | | | | | | | | | | |
4/29/25 16:33 | 4/29/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 8 | S | -4,870 | 42.96 | 0 | -113 | | 432 | D | | | | | | | | | | | | | | |
4/29/25 06:14 | 4/25/25 | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | 4 | P | 165 | 9.11 | 0 | 18 | 0 | 5,571 | D | | | | | | | | | | | | | | |
4/28/25 18:22 | 4/24/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 9 | M.d | 3,043 | 34.58 | 0 | 88 | 107 | 170 | D | | | | | | | | | | | | | | |
4/28/25 18:22 | 4/24/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 9 | S.d | -3,043 | 34.58 | 0 | -88 | | 170 | D | | | | | | | | | | | | | | |
4/28/25 07:07 | 2/7/25 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Xiao Ting | MA | D | | 2 | P | 155 | 7.76 | 0 | 20 | 74 | 47 | D | | | | | | | | | | | | | | |
4/25/25 20:20 | 4/25/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Weinhoff Gregory M | X0 | O | Chief Bu | 4 | S.d | -537 | 12.42 | 0 | -43 | | 134 | D | | | | | | | | | | | | | | |
4/25/25 19:01 | 3/13/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Slingsby Brian Taylor | WA | DT | | 1 | P | 3,500 | 13.50 | 0 | 259 | 3 | 8,904 | I | | | | | | | | | | | | | | |
4/25/25 16:01 | 3/24/25 | GYRE | Gyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ye Weiguo | CA | O | COO | 1 | M.dm | 488 | 0.7500 | 0 | 650 | | 650 | D | | | | | | | | | | | | | | |
4/24/25 16:40 | 4/23/25 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rangwala Reshma | MA | O | EVP,Chie | 2 | S | -25 | 6.28 | 0 | -4 | | 29 | D | | | | | | | | | | | | | | |
4/24/25 16:28 | 4/22/25 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | 5 | S.d | -8,981 | 28.78 | 0 | -312 | | 6,306 | I | | | | | | | | | | | | | | |
4/24/25 16:06 | 4/22/25 | RCKT | Rocket Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Militello John | NJ | O | See Rema | 2 | S | -34 | 9.87 | 0 | -3 | | 66 | D | | | | | | | | | | | | | | |
4/23/25 18:00 | 4/21/25 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Farnum Rhonda | CA | O | SVP,COMM | 1 | S | -36 | 9.00 | 0 | -4 | | 370 | D | | | | | | | | | | | | | | |
4/23/25 17:09 | 4/21/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | O | CHIEF SC | 2 | S | -338 | 19.31 | 0 | -18 | | 1,003 | I | | | | | | | | | | | | | | |
4/23/25 16:30 | 4/22/25 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Ali Asif | CA | O | CFO | 3 | S.d | -1,914 | 37.13 | 0 | -52 | | 63 | D | | | | | | | | | | | | | | |
4/23/25 16:15 | 4/21/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Saggar Rajeev | NC | O | Chief Me | 2 | S | -84 | 13.61 | 0 | -6 | | 266 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/21/25 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Venker Eric | X0 | O | P,COO | 8 | M.dm | 21,778 | 6.83 | 0 | 3,188 | | 1,127 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/21/25 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Venker Eric | X0 | O | P,COO | 8 | S.dm | -21,778 | 6.83 | 0 | -3,188 | | 1,127 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Cohen Paul | NJ | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Odysseas Kostas D | CT | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Horn Keith | NJ | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Sullivan Diane E. | NJ | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Sterling Louis III | NJ | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | 30 | 4 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Bonfiglio Patrice Eadon | NJ | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | O'Connor Oliver | NJ | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 21:00 | 4/18/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Dipaolo Mark | CT | D | | 1 | M.d | 0 | 0.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
4/22/25 17:43 | 4/21/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Saha Saurabh | X0 | DO | CEO | 3 | S.m | -2,476 | 15.00 | 0 | -165 | | 369 | D | | | | | | | | | | | | | | |
4/22/25 17:38 | 4/30/24 | VREO | Vireo Growth Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Chicago Atlantic Opportunity Portfolio, LP | IL | T | | 1 | P.dm | 32 | 0.1600 | 0 | 197 | 0 | 110,909 | D | | | | | | | | | | | | | | |
4/22/25 16:33 | 4/22/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 15 | M.d | 1,292 | 33.07 | 0 | 39 | 39 | 140 | D | | | | | | | | | | | | | | |
4/22/25 16:33 | 4/22/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 15 | S.d | -1,292 | 33.07 | 0 | -39 | | 140 | D | | | | | | | | | | | | | | |
4/22/25 16:30 | 4/21/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Dwek Raymond | MD | D | | 6 | M.d | 4,605 | 230.23 | 0 | 20 | | 2 | D | | | | | | | | | | | | | | |
4/22/25 16:30 | 4/21/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Dwek Raymond | MD | D | | 6 | S.d | -4,605 | 230.23 | 0 | -20 | | 2 | D | | | | | | | | | | | | | | |
4/22/25 07:01 | 4/17/25 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | McArthur James G | MA | DO | P,CEO | 2 | P | 61 | 1.19 | 0 | 52 | 83 | 114 | D | | | | | | | | | | | | | | |
4/21/25 17:55 | 4/17/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kintz Samuel | CO | DO | P,CEO | 2 | S | -342 | 19.57 | 0 | -18 | | 990 | I | | | | | | | | | | | | | | |
4/21/25 17:42 | 4/21/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | | 2 | M.d | 893 | 22.34 | 0 | 40 | | 25 | D | | | | | | | | | | | | | | |
4/21/25 17:42 | 4/21/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | | 2 | S.d | -893 | 22.34 | 0 | -40 | | 25 | D | | | | | | | | | | | | | | |
4/21/25 17:00 | 4/18/25 | SIGA | Siga Technologies Inc | DE | Health | Drug | Pharmaceutical Preparations | Miller Larry R. | NY | O | GC | 2 | M.d | 0 | 0.00 | 0 | 14 | 56 | 38 | D | | | | | | | | | | | | | | |
4/21/25 16:05 | 4/17/25 | MRUS | Merus N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Lundberg Sven Ante | P7 | DO | P,CEO,PE | 2 | M.d | 806 | 17.27 | 0 | 47 | | 41 | D | | | | | | | | | | | | | | |
4/21/25 16:04 | 4/17/25 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Warren Eric | MI | O | Chief Co | 3 | S | -4 | 1.50 | 0 | -3 | | 370 | D | | | | | | | | | | | | | | |
4/21/25 16:03 | 4/17/25 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Halladay Benjamin | MI | O | CFO | 3 | S | -5 | 1.48 | 0 | -4 | | 482 | D | | | | | | | | | | | | | | |
4/18/25 17:27 | 4/16/25 | GYRE | Gyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Eastling Thomas Wilson | CA | D | | 1 | M.d | 104 | 6.93 | 0 | 15 | | 15 | D | | | | | | | | | | | | | | |
4/18/25 15:17 | 4/16/25 | ZYME | Zymeworks Inc. | | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | 7 | P.m | 25,436 | 12.06 | 0 | 2,108 | 13 | 17,828 | I | | | | | | | | | | | | | | |
4/17/25 17:41 | 4/15/25 | NAMS | Newamsterdam Pharma Co N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Kling Douglas F | P7 | O | COO | 8 | M.dm | 1,119 | 1.77 | 0 | 633 | | 44 | D | | | | | | | | | | | | | | |
4/17/25 17:41 | 4/15/25 | NAMS | Newamsterdam Pharma Co N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Kling Douglas F | P7 | O | COO | 8 | S.dm | -1,119 | 1.77 | 0 | -633 | | 44 | D | | | | | | | | | | | | | | |
4/17/25 16:55 | 4/15/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 6 | M.d | 8,284 | 51.14 | 0 | 162 | 186 | 249 | D | | | | | | | | | | | | | | |
4/17/25 16:55 | 4/15/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 6 | S.d | -8,284 | 51.14 | 0 | -162 | | 249 | D | | | | | | | | | | | | | | |
4/17/25 16:53 | 4/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Birchler Brian | CA | O | EVP,Corp | 2 | M.d | 19 | 7.55 | 0 | 3 | 5 | 57 | D | | | | | | | | | | | | | | |
4/17/25 16:53 | 4/16/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Birchler Brian | CA | O | EVP,Corp | 2 | S.d | -19 | 7.55 | 0 | -3 | | 57 | D | | | | | | | | | | | | | | |
4/17/25 16:53 | 4/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Jenne Kyle | CA | O | EVP,Chf | 2 | M.d | 86 | 5.61 | 0 | 15 | | 11 | D | | | | | | | | | | | | | | |
4/17/25 16:53 | 4/16/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Jenne Kyle | CA | O | EVP,Chf | 2 | S.d | -86 | 5.61 | 0 | -15 | | 11 | D | | | | | | | | | | | | | | |
4/17/25 16:53 | 4/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | 2 | M.d | 112 | 7.56 | 0 | 15 | 73 | 35 | D | | | | | | | | | | | | | | |
4/17/25 16:53 | 4/16/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | 2 | S.d | -112 | 7.56 | 0 | -15 | | 35 | D | | | | | | | | | | | | | | |
4/17/25 16:05 | 4/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Samayoa Phillip | MA | O | CHIEF SC | 1 | M.d | 0 | 0.00 | 0 | 1 | 1 | 129 | D | | | | | | | | | | | | | | |
4/17/25 16:05 | 4/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | McDonough Geoff | MA | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 5 | 0 | 1,851 | D | | | | | | | | | | | | | | |
4/17/25 16:05 | 4/15/25 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Le-Nguyen Quoc | CA | O | See Rema | 1 | S | -91 | 5.95 | 0 | -15 | | 343 | D | | | | | | | | | | | | | | |
4/17/25 16:05 | 4/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Paone Antoinette | MA | O | COO | 1 | M.d | 0 | 0.00 | 0 | 2 | 7 | 23 | D | | | | | | | | | | | | | | |
4/17/25 16:05 | 4/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Howze Yalonda | MA | O | GC | 1 | M.d | 0 | 0.00 | 0 | 3 | 22 | 19 | D | | | | | | | | | | | | | | |
4/17/25 16:05 | 4/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Conway Kevin John | MA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 1 | 3 | 18 | D | | | | | | | | | | | | | | |
4/17/25 06:10 | 4/15/25 | RNXT | Renovorx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Agah Ramtin | CA | DO | Chief Me | 4 | P | 76 | 0.8323 | 0 | 91 | 9 | 1,113 | D | | | | | | | | | | | | | | |
4/16/25 18:00 | 4/15/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 7 | M.d | 1,931 | 32.87 | 0 | 59 | 159 | 96 | D | | | | | | | | | | | | | | |
4/16/25 18:00 | 4/15/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 7 | S.d | -1,931 | 32.87 | 0 | -59 | | 96 | D | | | | | | | | | | | | | | |
4/16/25 18:00 | 4/15/25 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Le Goff Corinne | PA | O | Chief Co | 2 | M.d | 0 | 0.00 | 0 | 79 | | 42 | D | | | | | | | | | | | | | | |
4/16/25 17:39 | 4/14/25 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | | 4 | M.d | 1,710 | 21.37 | 0 | 80 | | 12 | D | | | | | | | | | | | | | | |
4/16/25 17:39 | 4/14/25 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | | 4 | S.d | -1,710 | 21.37 | 0 | -80 | | 12 | D | | | | | | | | | | | | | | |
4/16/25 17:12 | 4/14/25 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Wang Xiaodong | E9 | DH | Chair, S | 7 | M.d | 33,358 | 128.94 | 0 | 259 | 3 | 10,325 | D | | | | | | | | | | | | | | |
4/16/25 17:12 | 4/14/25 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Wang Xiaodong | E9 | DH | Chair, S | 7 | S.d | -33,358 | 128.94 | 0 | -259 | | 10,325 | D | | | | | | | | | | | | | | |
4/16/25 17:06 | 4/14/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Schundler Russell | NC | O | GC | 3 | S.d | -95 | 10.32 | 0 | -9 | | 591 | D | | | | | | | | | | | | | | |
4/16/25 17:05 | 4/14/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Jeffs Roger | NC | DO | CEO | 1 | S | -192 | 13.57 | 0 | -14 | | 2,595 | D | | | | | | | | | | | | | | |
4/16/25 17:04 | 4/15/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Moomaw Scott | NC | O | Chief Co | 3 | S.d | -55 | 9.43 | 0 | -6 | | 218 | D | | | | | | | | | | | | | | |
4/16/25 17:03 | 4/14/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Kaseta Michael | NC | O | CFO,COO | 3 | S.d | -126 | 10.95 | 0 | -12 | | 405 | D | | | | | | | | | | | | | | |
4/16/25 17:00 | 4/15/25 | RAPP | Rapport Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bredt David | MA | O | Chief Sc | 2 | S | -174 | 10.21 | 0 | -17 | | 469 | D | | | | | | | | | | | | | | |
4/16/25 16:38 | 4/14/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 9 | M.d | 861 | 12.73 | 0 | 68 | 459 | 82 | D | | | | | | | | | | | | | | |
4/16/25 16:38 | 4/14/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 9 | S.d | -861 | 12.73 | 0 | -68 | | 82 | D | | | | | | | | | | | | | | |
4/16/25 16:35 | 4/15/25 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | English Emily | MD | O | Chief Op | 1 | M.d | 25 | 3.30 | 0 | 8 | 19 | 48 | D | | | | | | | | | | | | | | |
4/16/25 16:25 | 4/15/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Henderson John T | CA | D | | 2 | M.d | 248 | 10.67 | 0 | 23 | 54 | 66 | D | | | | | | | | | | | | | | |
4/16/25 16:25 | 4/15/25 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Henderson John T | CA | D | | 2 | S.d | -248 | 10.67 | 0 | -23 | | 66 | D | | | | | | | | | | | | | | |
4/16/25 09:34 | 4/1/25 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | 1 | M.d | 126 | 52.30 | 0 | 2 | 8 | 33 | D | | | | | | | | | | | | | | |
4/16/25 06:08 | 4/15/25 | RNXT | Renovorx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bagai Shaun | CA | DO | CEO | 3 | P | 23 | 0.8517 | 0 | 28 | 9 | 320 | D | | | | | | | | | | | | | | |
4/15/25 20:39 | 4/14/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | 6 | M.d | 1,066 | 12.15 | 0 | 88 | 106 | 171 | D | | | | | | | | | | | | | | |
4/15/25 20:39 | 4/14/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | 6 | S.d | -1,066 | 12.15 | 0 | -88 | | 171 | D | | | | | | | | | | | | | | |
4/15/25 20:36 | 4/11/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levy Adam Scott | PA | O | CFO,Secr | 1 | S | -130 | 12.06 | 0 | -11 | | 215 | D | | | | | | | | | | | | | | |
4/15/25 20:33 | 4/11/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | 1 | S | -187 | 12.19 | 0 | -15 | | 862 | D | | | | | | | | | | | | | | |
4/15/25 17:30 | 3/31/25 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | D | | 1 | S | -7 | 9.85 | 0 | -1 | | 18 | D | | | | | | | | | | | | | | |
4/15/25 16:31 | 4/14/25 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akinsanya Karen | NY | O | P of R,D | 2 | M.d | 472 | 14.12 | 0 | 33 | | 16 | D | | | | | | | | | | | | | | |
4/15/25 16:31 | 4/14/25 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akinsanya Karen | NY | O | P of R,D | 2 | S.d | -472 | 14.12 | 0 | -33 | | 16 | D | | | | | | | | | | | | | | |
4/15/25 16:30 | 4/13/25 | CELU | Celularity Inc | DE | Health | Drug | Pharmaceutical Preparations | Brigido Stephen | NJ | O | P,Functi | 2 | M.d | 0 | 0.00 | 0 | 11 | | 9 | D | | | | | | | | | | | | | | |
4/15/25 16:30 | 4/13/25 | CELU | Celularity Inc | DE | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | NJ | DO | CEO | 1 | M.d | 0 | 0.00 | 0 | 3 | 19 | 20 | D | | | | | | | | | | | | | | |
4/15/25 16:30 | 4/13/25 | CELU | Celularity Inc | DE | Health | Drug | Pharmaceutical Preparations | Haines John R | NJ | O | Senior E | 2 | M.d | 0 | 0.00 | 0 | 22 | 289 | 29 | D | | | | | | | | | | | | | | |
4/15/25 16:30 | 4/13/25 | CELU | Celularity Inc | DE | Health | Drug | Pharmaceutical Preparations | Beers David C | NJ | O | CFO | 2 | M.d | 0 | 0.00 | 0 | 14 | 289 | 18 | D | | | | | | | | | | | | | | |
4/15/25 14:02 | 4/10/25 | RMTI | Rockwell Medical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Irrevocable Larson Family Investment Trust | TX | T | | 1 | P.m | 94 | 1.07 | 0 | 88 | 3 | 3,558 | D | | | | | | | | | | | | | | |
4/15/25 12:50 | 4/2/25 | NBY | Novabay Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | | 7 | P.m | 314 | 0.6251 | 0 | 502 | 97 | 1,020 | D | | | | | | | | | | | | | | |
4/15/25 07:59 | 3/24/25 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Thompson Tommy G | FL | D | | 6 | M.d | 2,470 | 131.22 | 0 | 19 | 57 | 52 | D | | | | | | | | | | | | | | |
4/15/25 07:59 | 3/24/25 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Thompson Tommy G | FL | D | | 6 | S.d | -2,470 | 131.22 | 0 | -19 | | 52 | D | | | | | | | | | | | | | | |
4/15/25 07:59 | 4/14/25 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Walker Marlan D | FL | O | CEO | 3 | P.dm | 2 | 0.2242 | 0 | 11 | 18 | 74 | D | | | | | | | | | | | | | | |
4/14/25 19:26 | 4/11/25 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | 1 | M.d | 166 | 8.00 | 0 | 21 | 19 | 132 | D | | | | | | | | | | | | | | |
4/14/25 18:57 | 4/10/25 | RCKT | Rocket Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Gaurav | NJ | DO | CEO | 2 | P | 274 | 7.55 | 0 | 36 | 3 | 1,199 | D | | | | | | | | | | | | | | |
4/14/25 18:23 | 4/11/25 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Cline Christopher R. | CA | O | CFO | 2 | S.d | -105 | 20.06 | 0 | -5 | | 90 | D | | | | | | | | | | | | | | |
4/14/25 17:58 | 4/10/25 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | D | | 6 | M.d | 502 | 38.05 | 0 | 13 | | 0 | D | | | | | | | | | | | | | | |
4/14/25 17:58 | 4/10/25 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | D | | 6 | S.d | -502 | 38.05 | 0 | -13 | -100 | 0 | D | | | | | | | | | | | | | | |
4/14/25 17:17 | 4/11/25 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Lurker Nancy | | D | | 1 | M.d | 0 | 0.00 | 0 | 6 | | 5 | D | | | | | | | | | | | | | | |
4/14/25 16:17 | 4/14/25 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Cook Meredith | MN | O | SVP,GC,S | 3 | S | -77 | 63.94 | 0 | -1 | | 82 | D | | | | | | | | | | | | | | |
4/14/25 16:13 | 4/10/25 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Cornelissen Bart Jan | CA | O | SVP,CFO | 1 | S | -30 | 8.06 | 0 | -4 | | 61 | D | | | | | | | | | | | | | | |
4/11/25 21:57 | 4/9/25 | KROS | Keros Therapeutics, Inc. | | Health | Drug | Pharmaceutical Preparations | Adar1 Capital Management, LLC | TX | T | | 1 | P.d | 9,465 | 10.13 | 0 | 934 | 21 | 5,391 | I | | | | | | | | | | | | | | |
4/11/25 21:45 | 4/9/25 | OSTX | Os Therapies Inc | DE | Health | Drug | Pharmaceutical Preparations | Auerbach Shalom | NY | T | | 2 | S.m | -366 | 2.29 | 0 | -160 | | 2,770 | I | | | | | | | | | | | | | | |
4/11/25 18:20 | 4/9/25 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | 4 | S.dm | -9,908 | 12.50 | 0 | -793 | | 4,062 | D | | | | | | | | | | | | | | |
4/11/25 18:00 | 4/10/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 4 | S | -3,970 | 43.27 | 0 | -92 | | 686 | D | | | | | | | | | | | | | | |
4/11/25 17:29 | 4/9/25 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Springer Timothy A | MA | DT | | 2 | P.m | 2,894 | 12.11 | 0 | 239 | 3 | 9,631 | M | | | | | | | | | | | | | | |
4/11/25 17:22 | 4/1/25 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | 1 | M | 0 | 0.00 | 0 | 14 | 21 | 82 | D | | | | | | | | | | | | | | |
4/11/25 17:22 | 4/9/25 | KALV | Kalvista Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venrock Healthcare Capital Partners Iii, L.P. | NY | T | | 5 | P.m | 4,730 | 9.77 | 0 | 484 | 5 | 9,452 | I | | | | | | | | | | | | | | |
4/11/25 17:20 | 4/1/25 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Guy Wendy | MD | O | Chief Ad | 1 | M | 0 | 0.00 | 0 | 14 | 72 | 35 | D | | | | | | | | | | | | | | |
4/11/25 17:17 | 4/1/25 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bigora Sian | MD | O | Chief De | 1 | M | 0 | 0.00 | 0 | 15 | 60 | 40 | D | | | | | | | | | | | | | | |
4/11/25 17:16 | 4/1/25 | PCSA | Processa Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young David | MD | DO | P Resear | 1 | M | 0 | 0.00 | 0 | 17 | 7 | 278 | D | | | | | | | | | | | | | | |
4/11/25 13:23 | 4/10/25 | GOVX | Geovax Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spencer John N Jr | GA | D | | 1 | P | 10 | 0.9800 | 0 | 10 | 713 | 11 | D | | | | | | | | | | | | | | |
4/10/25 19:06 | 4/9/25 | PVLA | Palvella Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Jenkins George M | PA | D | | 1 | P | 101 | 20.20 | 0 | 5 | 3 | 197 | M | | | | | | | | | | | | | | |
4/10/25 19:02 | 4/8/25 | RNXT | Renovorx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kocak Ron | CA | O | VP Contr | 1 | P.m | 10 | 0.7948 | 0 | 13 | | 13 | D | | | | | | | | | | | | | | |
4/10/25 17:07 | 4/10/25 | OPK | Opko Health, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Frost Phillip Md Et Al | FL | DOT | CEO,CB | 6 | P.d | 1,237 | 1.61 | 0 | 767 | 0 | 247,698 | I | | | | | | | | | | | | | | |
4/10/25 16:15 | 4/8/25 | ACUT | Accustem Sciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cerrone Gabriele M | NY | DT | | 2 | P.m | 104 | 0.5428 | 0 | 191 | 4 | 4,911 | I | | | | | | | | | | | | | | |
4/10/25 16:07 | 4/9/25 | RCKT | Rocket Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Kinnari | NJ | O | See Rema | 2 | P | 163 | 6.02 | 0 | 27 | 5 | 576 | I | | | | | | | | | | | | | | |
4/10/25 16:02 | 4/8/25 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fouse Jacqualyn A | MA | D | | 2 | M.d | 194 | 8.29 | 0 | 23 | 19 | 149 | D | | | | | | | | | | | | | | |
4/10/25 16:02 | 4/10/25 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fouse Jacqualyn A | MA | D | | 2 | S.d | -194 | 8.29 | 0 | -23 | | 149 | D | | | | | | | | | | | | | | |
4/10/25 16:01 | 4/10/25 | GOVX | Geovax Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sharkey John W. | GA | O | VP,Busin | 1 | P | 6 | 0.9900 | 0 | 6 | 999% | 6 | D | | | | | | | | | | | | | | |
4/10/25 08:39 | 4/8/25 | MBX | Mbx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pescovitz Ora H. | IN | D | | 1 | P | 45 | 5.89 | 0 | 8 | 46 | 24 | D | | | | | | | | | | | | | | |
4/9/25 21:30 | 4/8/25 | RNXT | Renovorx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Marton Laurence | CA | D | | 1 | P | 10 | 0.8480 | 0 | 12 | 36 | 46 | D | | | | | | | | | | | | | | |
4/9/25 16:44 | 4/7/25 | XOMA | Xoma Royalty Corp | | Health | Drug | Pharmaceutical Preparations | Sitko Bradley | CA | O | Chief In | 3 | P | 174 | 23.63 | 0 | 7 | 53 | 21 | D | | | | | | | | | | | | | | |
4/9/25 16:44 | 4/7/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | X0 | DO | CB,CEO | 3 | M.d | 0 | 0.00 | 0 | 29 | 17 | 206 | D | | | | | | | | | | | | | | |
4/9/25 16:43 | 4/7/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 3 | M.d | 0 | 0.00 | 0 | 8 | 15 | 57 | D | | | | | | | | | | | | | | |
4/9/25 16:41 | 4/7/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Megna Michael R | X0 | O | CHIEF AC | 5 | M.d | 304 | 10.95 | 0 | 28 | 576 | 33 | D | | | | | | | | | | | | | | |
4/9/25 16:25 | 4/7/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Anish | CO | O | COO | 3 | S.d | -409 | 20.47 | 0 | -20 | | 330 | I | | | | | | | | | | | | | | |
4/9/25 07:25 | 3/1/25 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Fishman Peter L. | NJ | O | SVP,CFO | 1 | M.dm | 0 | 0.00 | 0 | 5 | 7 | 77 | D | | | | | | | | | | | | | | |
4/8/25 21:52 | 4/4/25 | VREO | Vireo Growth Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Chicago Atlantic Credit Opportunities, LLC | IL | T | | 7 | P.dm | 20,231 | 0.6210 | 0 | 32,579 | 35 | 126,744 | D | | | | | | | | | | | | | | |
4/8/25 21:36 | 3/26/25 | NTHI | Neonc Technologies Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Garnett Keithly | CA | DO | CFO | 1 | S.ad | -164 | 24.85 | 0 | -7 | | 321 | I | | | | | | | | | | | | | | |
4/8/25 21:36 | 3/26/25 | NTHI | Neonc Technologies Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Heshmatpour Amir F | CA | D | | 1 | S.ad | -956 | 24.85 | 0 | -38 | | 6,802 | I | | | | | | | | | | | | | | |
4/8/25 21:36 | 3/26/25 | NTHI | Neonc Technologies Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Walters Patrick | CA | O | COO | 1 | S.ad | -294 | 24.85 | 0 | -12 | | 876 | I | | | | | | | | | | | | | | |
4/8/25 21:35 | 3/26/25 | NTHI | Neonc Technologies Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chiang Ming-Fu (Alan) | CA | D | | 1 | S.ad | -1,434 | 24.85 | 0 | -58 | | 2,180 | M | | | | | | | | | | | | | | |
4/8/25 21:35 | 3/26/25 | NTHI | Neonc Technologies Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chen Thomas C | | DOT | CEO | 1 | S.ad | -975 | 24.85 | 0 | -39 | | 4,843 | I | | | | | | | | | | | | | | |
4/8/25 21:30 | 4/4/25 | NUVB | Nuvation Bio Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hung David | NY | DOT | P,CEO | 1 | P.m | 820 | 1.64 | 0 | 500 | 1 | 58,781 | D | | | | | | | | | | | | | | |
4/8/25 20:22 | 4/7/25 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quisel John D | MA | DO | CEO | 2 | M.d | 311 | 24.76 | 0 | 13 | 8 | 162 | D | | | | | | | | | | | | | | |
4/8/25 19:24 | 4/4/25 | ARDX | Ardelyx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Raab Michael | MA | DO | P,CEO | 5 | M.d | 585 | 3.95 | 0 | 148 | 10 | 1,661 | D | | | | | | | | | | | | | | |
4/8/25 19:24 | 4/4/25 | ARDX | Ardelyx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Raab Michael | MA | DO | P,CEO | 5 | S.d | -585 | 3.95 | 0 | -148 | | 1,661 | D | | | | | | | | | | | | | | |
4/8/25 19:05 | 3/31/25 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rouan Sarah Kathryn | CA | D | | 2 | P | 60 | 24.15 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
4/8/25 17:32 | 4/4/25 | OKUR | Onkure Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Saccomano Nicholas A | CO | DO | P,CEO | 1 | S.m | -3 | 2.94 | 0 | -1 | | 4 | D | | | | | | | | | | | | | | |